New study in @DovePress co-authored by @DeptPopMed/@HealthPolicyDPM Associate Professor Anita K. Wagner suggests in… https://t.co/RxWKswgcRy
Online now: @DeptPopMed's Di Shu, @JessGeraldYoung, @darrentoh_epi developed, validated a distributed modified… https://t.co/meOXD8Gh3A
Last Friday, @DeptPopMed Professor and Chair Richard Platt took part in an expert panel: Millions More People, Stro… https://t.co/RNYGvWUqFm
Welcome to our spotlight series, where we look beyond the CV and learn more about our investigators. Meet Hao Yu, PhD, a new faculty member studying the effects of large-scale state or national health policies on population and patient-centered measures.
Updated guidelines from the American Association for the Study of Liver Diseases (AASLD) and Infectious Diseases Society of America (IDSA) for the treatment of hepatitis C now allow for a shorter 8-week treatment regimen for Black patients. These revised guidelines are based in part on a study led by Assistant Professor Julia Marcus and colleagues from Kaiser Permanente comparing the effectiveness of 8- and 12-week treatment regimens for the treatment of hepatitis C.